HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Daxor files 510(k) for injection syringe:

This article was originally published in Clinica

Executive Summary

Daxor has filed a 510(k) submission with the US FDA for a quantitative syringe kit for use with its BVA-100 blood volume analyser. The syringe is designed to deliver more than 99.9% of its content in diagnostic studies in which a precise and complete injection is required. Daxor, based in New York, has been awaiting clearance for its BVA-100 system since November last year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083711

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel